Prediction: TMC The Metals Company Will Soar Over the Next Year. Here's 1 Reason Why.

TMC The Metals Company could begin generating revenue by the end of 2027, with regulatory review in an accelerated U.S. pathway expected to conclude by early 2027. The company is targeting polymetallic nodules in the Clarion-Clipperton Zone that contain cobalt, copper, manganese, and nickel, but the project remains highly speculative and dependent on continued regulatory support. The article frames the stock as a high-risk way to gain exposure to critical mineral supply chains rather than a near-term operating business.

Analysis

The market is still treating TMC as a binary pre-revenue story, but the more important second-order effect is that a credible U.S.-backed regulatory path changes the optionality of the entire deep-sea mining stack. If the process keeps advancing, the first beneficiaries are not just TMC equity holders; they are the industrial and logistics partners that de-risk extraction, processing, and offtake, while more established battery-metal miners face a future where a new supply source can cap long-duration scarcity premiums. The key here is timing: even an early-2027 approval window is long enough for the equity to trade more on policy headlines than on operating fundamentals.

The biggest near-term catalyst is not actual production, but confirmation that the company can move from political narrative to legal certainty without a fresh injunction or international pushback. That creates a classic reflexive setup: each incremental approval could compress implied discount rates and expand access to capital, which matters more for a pre-revenue name than the eventual tonnage. But the same feature makes the stock fragile—any sign that Washington is softening, or that legal challenges materially extend the timeline, can re-rate the name sharply because there is no cash-flow floor to anchor valuation.

Contrarianly, the cleaner trade may be in the incumbents, not TMC. If markets start assigning even modest probability to future nodules supply, the most exposed names are higher-cost or lower-quality nickel/copper/manganese producers with long reserve lives priced on scarcity assumptions; they could see multiple compression well before TMC lifts a tonne. Conversely, if the regulatory path stalls, TMC likely bleeds value faster than the broader critical-minerals basket because the equity is dominated by deadline risk rather than asset quality.

Key Decisions for Investors

• Speculative long TMCWW or TMC common only as a catalyst trade into early-2027 regulatory milestones; size small, because upside is multiple-expansion on approval but downside is dilution and timeline slippage.
• Buy 6-12 month call spreads on TMC instead of stock if available liquidity supports it; this captures policy-driven convexity while capping premium burn if the approval process stalls.
• Pair trade: short higher-cost nickel/copper producers with balance-sheet leverage against long TMC on a basket basis; the thesis is that the market will discount future nodules supply before it exists, compressing scarcity multiples in the incumbents.
• Use a event-driven approach: add only on concrete regulatory confirmations, not on speculative headlines, because the stock’s edge is in repricing probability, not current fundamentals.
• If TMC rallies sharply on a headline, take partial profits quickly; this is a binary policy name where the left tail remains wider than the right tail until financing and legal certainty are both visible.